Escalas de puntuación de riesgo de Diabetes de la India (IDRS) y Finlandés (FINDRISC) Revisión Sistemática)

Abstract

The change in population lifestyle and adoption of unhealthy dietary practices, coupled with decreased physical activity, has led to an increase in cardiometabolic disease. According to the International Diabetes Federation, it is projected that by 2045, 629 million people will be diagnosed with diabetes. Many patients are unaware of their diabetic condition because this disease, in its initial stages, can remain asymptomatic, leading to significant delays in diagnosis. Objective: To compare prediction scales for Type 2 Diabetes Mellitus: Finnish Diabetes Risk Score (FINDRISC) and Indian Diabetes Risk Score (IDRS) in adults aged 20 to 65. Methodology: A systematic review following the PRISMA 2020 methodology was conducted. Results: FINDRISC and IDRS are helpful predictors of Diabetes Mellitus and support early diagnosis of prediabetes and diabetes when their values are ≥ nine and > 60, respectively. The most specific confirmation methods for DM2 in moderate and high-risk patients are oral glucose tolerance tests and glycated hemoglobin. Conclusion: Diabetes risk scales should be used for all primary care consultation patients. In patients with moderate or high risk, a confirmatory test should be requested for early diagnosis of prediabetes and/or diabetes. Keywords: Diabetes Mellitus, FINDRISC, IDRS, sensitivity, specificity